Original Research
Published on 29 Jun 2022
DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promising Combination for Therapy of Prostate Cancer Related Bone Metastases
in Radiopharmacy and Radiochemistry
![DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promising Combination for Therapy of Prostate Cancer Related Bone Metastases](https://www.frontiersin.org/files/myhome article library/892147/892147_Thumb_400.jpg)
- 2,117 views
- 5 citations
Original Research
Published on 29 Jun 2022
in Radiopharmacy and Radiochemistry
Original Research
Published on 10 May 2022
in Radiopharmacy and Radiochemistry
Original Research
Published on 14 Apr 2022
in Radiopharmacy and Radiochemistry
Review
Published on 25 Mar 2022
in Radiopharmacy and Radiochemistry
Original Research
Published on 20 Jan 2022
in Radiopharmacy and Radiochemistry
Original Research
Published on 13 Dec 2021
in Radiopharmacy and Radiochemistry
Original Research
Published on 18 Nov 2021
in Radiopharmacy and Radiochemistry
Original Research
Published on 12 Nov 2021
in Radiopharmacy and Radiochemistry